openPR Logo
Press release

Growth Hormone Deficiency Market Forecast 2024-2034: CAGR of 4.4% Drives Steady Expansion - Analysis by TMR

07-07-2025 06:46 AM CET | Health & Medicine

Press release from: Transparency Market Research

Growth Hormone Deficiency Market

Growth Hormone Deficiency Market

The global Growth Hormone Deficiency (GHD) market, valued at US$ 4.3 Bn in 2023, is poised for stable expansion over the next decade. According to recent market projections, the industry is expected to grow at a CAGR of 4.4% between 2024 and 2034, reaching approximately US$ 7.0 Bn by 2034. The growth is being propelled by innovation, regulatory approvals, and strategic moves by leading biopharmaceutical companies.

Access key findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86221

Market Overview

Growth hormone deficiency is a rare but serious condition affecting both children and adults. It arises from inadequate secretion of growth hormone (GH) from the pituitary gland, leading to growth failure in children and a variety of metabolic disturbances in adults. The market is witnessing increasing awareness, improved diagnostic techniques, and a wider therapeutic scope. These trends are pushing the demand for efficient and long-acting hormone therapies, reshaping the treatment landscape globally.

Market Size and Growth

From US$ 4.3 Bn in 2023, the GHD market is set to ascend to US$ 7.0 Bn by 2034, buoyed by a consistent 4.4% CAGR. This growth trajectory is underpinned by rising incidences of pituitary disorders, increasing pediatric and adult populations diagnosed with GHD, and broader insurance coverage for hormone replacement therapies. Moreover, strategic collaborations, clinical advancements, and FDA approvals-like the 2020 approval of Sogroya (somapacitan) by Novo Nordisk-are expected to boost market penetration and revenue generation.

Market Segmentation

The market is segmented based on treatment type, route of administration, end-user, and geography. Treatment-wise, recombinant human growth hormones (rhGH) continue to dominate, accounting for the lion's share due to their high efficacy and safety profile. Subcutaneous injections remain the most preferred route of administration, while the emergence of long-acting injectables is transforming patient compliance. By end-user, hospitals and specialty clinics hold the largest market share, supported by the infrastructure needed for proper diagnosis and administration.

Regional Analysis

Regionally, North America leads the global GHD market, thanks to advanced healthcare systems, high diagnosis rates, and the presence of key players like Pfizer Inc., Eli Lilly and Company, and Novo Nordisk A/S. The Asia-Pacific region is projected to grow at the fastest rate, fueled by improving healthcare infrastructure in countries like China and India, increasing awareness, and supportive regulatory frameworks. Europe also holds a significant share due to sustained investments in biotechnology and life sciences.

Access our report for a comprehensive look at key insights - https://www.transparencymarketresearch.com/growth-hormone-deficiency-market.html

Market Drivers and Challenges

The market is driven by several critical factors. Among them are technological innovations, long-acting drug formulations, FDA approvals, and rising healthcare expenditure globally. In September 2020, Novo Nordisk's Sogroya gained FDA approval, marking a milestone in adult GHD treatment with once-weekly dosing. However, challenges such as high treatment costs, limited awareness in low-income regions, and stringent regulatory pathways continue to pose barriers to rapid adoption.

Market Trends

The trend toward long-acting growth hormone formulations is revolutionizing the patient experience, shifting away from daily injections to more manageable weekly dosing. Personalized medicine is another growing trend, with genetic profiling and biomarkers being integrated into GHD diagnosis and treatment strategies. Furthermore, digital health technologies such as auto-injectors and mobile health tracking systems are enhancing treatment adherence and outcomes.

Competitive Landscape

The GHD market is moderately consolidated, with a mix of established pharmaceutical giants and emerging biotech firms. Key players include Novo Nordisk A/S, Pfizer Inc., Merck KGaA, Eli Lilly and Company, Novartis AG, F. Hoffmann-La Roche AG, Ipsen Pharma, Ferring Pharmaceuticals, Anhui Anke Biotechnology, and Zhongshan Sinobioway Hygene Biomedicine. These companies are actively engaged in product launches, mergers, acquisitions, and R&D investments. Product pipelines are rich with next-generation therapies targeting improved safety, efficacy, and convenience.

Future Outlook

Looking ahead to 2034, the growth hormone deficiency market is expected to continue its steady ascent, shaped by advances in biologics, patient-centric innovations, and emerging markets. As regulatory bodies streamline approval processes and more patients gain access to insurance-covered treatments, the market will likely see increased penetration and competition. Continued investments in biotechnology, genomics, and formulation science will be vital for companies aiming to lead this dynamic market.

Want to know more? Get in touch now. - https://www.transparencymarketresearch.com/contact-us.html

More Trending Reports by Transparency Market Research -

Vendor Neutral Archive (VNA) Market - https://www.transparencymarketresearch.com/vendor-neutral-archive-market.html

Interleukins Market - https://www.transparencymarketresearch.com/interleukins-market.html

Injectable Cytotoxic Drugs Market - https://www.transparencymarketresearch.com/injectable-cytotoxic-drugs-market.html

Insulin-like Growth Factors Market - https://www.transparencymarketresearch.com/insulin-like-growth-factors-market.html

Inactivated Vaccines Market - https://www.transparencymarketresearch.com/inactivated-vaccines-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Growth Hormone Deficiency Market Forecast 2024-2034: CAGR of 4.4% Drives Steady Expansion - Analysis by TMR here

News-ID: 4093471 • Views:

More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 - Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth. Uncover essential discoveries and trends from
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Radiopharmaceuticals to Propel Market Expansion | Transparency Market Research, Inc
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth. Discover essential conclusions and data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100 Analysts' Viewpoint The Technetium‐99m
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to US$ 280 Million by 2030, Driven by Rising Equine Diseases and Diagnostic Advancements
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of 6.1%
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,

All 5 Releases


More Releases for GHD

GHD Announces Leadership Transition with Ian Fraser as New Chair
Transition continues GHD's model of employee ownership Former Asia Pacific CEO brings 30 years of global experience and industry service Image: https://www.globalnewslines.com/uploads/2025/07/c53af51f8fc913ec0b4d314fa5aae6f7.jpg Global professional services company, GHD, has appointed Ian Fraser as Chair of its Board, effective 1 July 2025. GHD reported gross revenue for the 2024 financial year of AUD 2.9 billion. The company is fully owned by its employees, with approximately a quarter of its 12,000 people being shareholders. Ian was most
Canadian Trade Mission to Southeast Asia Unlocks Energy and Infrastructure Oppor …
Image: https://www.globalnewslines.com/uploads/2025/03/de18378f3fd5f6b9d77a0da46b244ece.jpg Canada's renewables energy industry and GHD have locked onto the potential to capitalise on Southeast Asia's energy and infrastructure transition following a recent 300-person trade mission to the region led by the Canadian Commercial Corporation (CCC). With a focus on clean energy, water infrastructure, and economic collaboration, the delegation - featuring key industry leaders including GHD - played a pivotal role in identifying opportunities to support the region's ambitious sustainability
Growth Hormone Deficiency (GHD) Treatment Market
Growth Hormone Deficiency (GHD) Treatment Market: Overview The growth hormone deficiency (GHD) treatment market has made some notable strides on the back of the growing role of GH replacement therapy in managing GHD in adults. Advances in understanding clinical syndrome of GHD and understanding of diagnosis are key trends boosting the GHD treatment market. Clinical practices pertaining to pharmacological management of the syndrome in the GHD treatment market have made remarkable
Global Handhold Dryer Market 2019 - Remington, GHD, VALERA, CONFU
Handhold Dryer is an electromechanical device designed to dry the hair In 2019, the market size of Handhold Dryer is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. Apex Market Research,
Human Growth Hormones Deficiency (GHD) Drugs Market Assessment Global Market 201 …
Press Release – 30 Jan 2019 Research and Development News -- . . Latest Update "Global Human Growth Hormones Deficiency (GHD) Drugs Market Assessment: Current Market, Pipeline Review, Clinical Trials, Market Potential - Forecast to 2023" with Industries Survey | Global Current Growth and Future. ' ' The report presents the market potential of four major pipeline drugs (TransCon-hGH, Somapacitan, Somavaratan, Somatrogonmeant) for the treatment of human Growth Hormone Deficiency (GHD). These four drugs
Global Hair Brushes & Combs Market:Key Players-amika,Christophe Robin,Drybar,ghd …
This report studies the Hair Brushes & Combs market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. The global Hair Brushes & Combs market was million US$ in 2017 and is